诺和诺德寻求针对礼来减肥广告的初步禁令

路透中文
Yesterday
<a href="https://laohu8.com/S/NVO">诺和诺德</a>寻求针对<a href="https://laohu8.com/S/LLY">礼来</a>减肥广告的初步禁令

路透哥本哈根7月24日 - 诺和诺德(NOVOb.CO)周五表示,该公司正寻求美国法院颁发初步禁令,以立即阻止礼来公司(LLY.N)发布有关肥胖症和糖尿病药物的广告,这标志着两家企业之间的竞争进一步升级。

丹麦的诺和诺德与美国制药集团礼来正围绕肥胖症药物市场的主导权展开激烈争夺,分析师预计,仅在美国,该市场到本十年末的规模将 (link) 超过1,000亿美元。

诺和诺德周二宣布已起诉礼来公司 (link),称消费者在两家公司产品的比较方面被误导,并表示如果这家美国企业不主动撤下有争议的广告,将申请初步禁令。

礼来公司周五未立即回应置评请求。该美国集团周二表示,否认存在任何不当行为,坚持其广告内容,并将针对此次诉讼进行有力辩护。

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10